Openwater
Venture Round in 2024
Openwater is a medical technology startup founded in 2016 and based in San Francisco, California. The company specializes in developing advanced wearable devices that utilize novel optoelectronics to achieve MRI-like resolution for medical diagnostics and treatments. By employing LCDs with small pixels, Openwater's technology creates holographic images that reduce scattering, enabling physicians to visualize the inner workings of the body and brain at a cellular level. This innovation allows for precise diagnosis and targeted treatment of diseases by manipulating or destroying individual cells without damaging surrounding tissue. Openwater aims to revolutionize medical imaging and improve patient outcomes through its cutting-edge approach.
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
Ketos
Private Equity Round in 2024
Ketos, Inc., operating as Ketos7 Inc., specializes in providing innovative hardware and software analytics solutions for water management. Founded in 2015 and based in Milpitas, California, the company offers a vertically integrated water intelligence platform that includes industrial-grade hardware, an IoT communication framework, and a comprehensive software platform. Ketos focuses on real-time monitoring and analysis of water systems, enabling clients to measure and manage key water quality parameters such as pH, dissolved solids, hardness, turbidity, and salinity. Its technology is designed for a variety of applications, including agricultural, industrial, and municipal settings, and aims to enhance water efficiency and quality. By leveraging automated reporting and predictive analytics, Ketos provides actionable insights that help organizations address critical water management challenges effectively.
Juvena Therapeutics
Series A in 2022
Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company focuses on developing protein-based therapeutics aimed at promoting tissue rejuvenation, primarily targeting age-related conditions such as sarcopenia, wound healing, and neural regeneration. Juvena Therapeutics utilizes a drug discovery platform that screens for restored cellular functions to create innovative therapeutics that facilitate tissue regeneration and repair. By decoding secreted proteins, the company aims to address various chronic and rare diseases, ultimately enhancing the quality of life for elderly patients.
Gameto
Venture Round in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
AiFi Inc. is a technology company based in Santa Clara, California, that specializes in developing artificial intelligence-based software for cashier-free retail environments. Founded in 2016, AiFi's platform utilizes advanced computer vision and sensor networks to track shoppers as they navigate stores, manage their carts, and process transactions seamlessly. The technology is designed to be adaptable to a variety of store formats and can support operations in spaces up to 10,000 square feet without the need for shelf sensors. This flexibility allows retailers to implement autonomous shopping solutions that enhance customer experiences while providing valuable insights into inventory management and consumer behavior. AiFi partners with numerous global retailers, including ALDI South Group and Carrefour, to create customized shopping experiences that facilitate reliable, contactless operations. The company has established itself as a leader in the autonomous retail space, being recognized for having the highest number of computer vision-powered autonomous stores worldwide.
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.
Helaina is a biotechnology company dedicated to producing milk-equivalent baby formula designed as a breast milk alternative. By utilizing fermentation technology, Helaina creates bioactive proteins that replicate the functional proteins found in human breast milk, thereby offering a new category of functional food products. These products not only provide essential nutrients but also deliver immune benefits, positioning Helaina as a pioneer in the infant nutrition sector. The company's innovative approach aims to provide infants with nutritional options that closely resemble the composition and benefits of breast milk, addressing the needs of families seeking alternatives.
Mammoth Biosciences
Series D in 2021
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, founded in 2017 by CRISPR pioneer Jennifer Doudna and other key innovators. The company specializes in developing advanced CRISPR technologies, including its proprietary DETECTR platform, which enables the rapid detection of specific nucleic acids associated with various diseases. This platform facilitates diagnostic applications such as cancer screening, bacterial infections, and viral infections, allowing for real-time and simultaneous testing of multiple conditions. In addition to diagnostics, Mammoth Biosciences works on genome editing solutions for therapeutic purposes, targeting areas such as immuno-oncology, autoimmune diseases, and liver disorders. The company aims to democratize disease detection and enhance life science research through innovative, affordable, and efficient tools, while also leveraging its exclusive licensing of various Cas proteins for improved diagnostics and therapeutic applications.
Einride AB, established in 2016, specializes in sustainable freight transportation. Headquartered in Stockholm, Sweden, with additional offices in Gothenburg and Palo Alto, the company manufactures electric trucks, known as Einride Pods, for road freight. These vehicles are designed for autonomous operation, reducing emissions and enhancing safety. Einride also offers digital platforms for clients to plan, order, and track shipments, providing real-time data and insights. Notably, Einride became the first company to operate an autonomous, electric freight vehicle on a public road in 2019.
Bitwise Industries
Series B in 2021
Bitwise Industries Inc. is a technology ecosystem company based in Fresno, California, focused on enhancing the local technology landscape. Established in 2013, the company operates Geekwise Academy, which provides accelerated coding education aimed at individuals of all ages, particularly from marginalized backgrounds. In addition to educational services, Bitwise Industries runs a custom software development firm, Shift3 Technologies, that connects experienced developers with entry-level programmers to create software solutions. The company also fosters community and collaboration by developing tech venues and co-working spaces that serve as hubs for technologists and technology companies. Through these initiatives, Bitwise Industries aims to empower individuals with vital tech skills and create pathways to meaningful careers in the technology sector.
Ashvattha Therapeutics
Series B in 2021
Ashvattha Therapeutics, Inc. is a pharmaceutical company focused on developing innovative therapeutics that address unmet medical needs in neurology, oncology, ophthalmology, and inflammation. Founded in 2015 and headquartered in Redwood City, California, with research facilities in Baltimore, Maryland, the company specializes in hydroxyl dendrimer therapeutics. These products are designed to selectively target and treat diseases by engaging actively endocytosing cells such as reactive microglia and macrophages, which play a critical role in chronic inflammation and disease progression. By utilizing this precision targeting approach, Ashvattha Therapeutics aims to minimize off-target toxicity, systemic side effects, and immunogenicity often associated with conventional treatments, thereby enhancing treatment efficacy and patient outcomes. The company has a robust pipeline containing nine therapeutics across its areas of focus.
Air Protein
Series A in 2021
Air Protein is a Berkeley, California-based startup focused on developing sustainable protein derived from carbon dioxide in the air. The company employs a proprietary probiotic process to transform CO2 into protein-enriched food products, which can be used in various applications, including meat-free burgers, protein-enriched pasta, cereals, and beverages. By utilizing ordinary elements from the atmosphere, Air Protein produces its protein without hormones, pesticides, or herbicides, while also significantly reducing the land and water requirements compared to traditional meat production. This innovative approach allows meat lovers to enjoy sustainable food options that contribute to a more environmentally friendly future.
Aclima Inc. is a climate-tech company that specializes in designing and deploying large-scale environmental sensor networks. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Portland, Oregon, and New York City, Aclima focuses on measuring and analyzing air pollution and greenhouse gases with exceptional detail and precision. Its advanced measurement and analysis platforms generate real-time streaming data, which is processed and translated into actionable insights for governments, businesses, and communities through its professional analytics software, Aclima Pro. By providing block-by-block resolution and source-level insights, Aclima aims to catalyze significant climate action that protects public health, reduces emissions, and ensures clean air for all.
Ketos, Inc., operating as Ketos7 Inc., specializes in providing innovative hardware and software analytics solutions for water management. Founded in 2015 and based in Milpitas, California, the company offers a vertically integrated water intelligence platform that includes industrial-grade hardware, an IoT communication framework, and a comprehensive software platform. Ketos focuses on real-time monitoring and analysis of water systems, enabling clients to measure and manage key water quality parameters such as pH, dissolved solids, hardness, turbidity, and salinity. Its technology is designed for a variety of applications, including agricultural, industrial, and municipal settings, and aims to enhance water efficiency and quality. By leveraging automated reporting and predictive analytics, Ketos provides actionable insights that help organizations address critical water management challenges effectively.
AiFi
Funding Round in 2020
AiFi Inc. is a technology company based in Santa Clara, California, that specializes in developing artificial intelligence-based software for cashier-free retail environments. Founded in 2016, AiFi's platform utilizes advanced computer vision and sensor networks to track shoppers as they navigate stores, manage their carts, and process transactions seamlessly. The technology is designed to be adaptable to a variety of store formats and can support operations in spaces up to 10,000 square feet without the need for shelf sensors. This flexibility allows retailers to implement autonomous shopping solutions that enhance customer experiences while providing valuable insights into inventory management and consumer behavior. AiFi partners with numerous global retailers, including ALDI South Group and Carrefour, to create customized shopping experiences that facilitate reliable, contactless operations. The company has established itself as a leader in the autonomous retail space, being recognized for having the highest number of computer vision-powered autonomous stores worldwide.
Ashvattha Therapeutics
Convertible Note in 2020
Ashvattha Therapeutics, Inc. is a pharmaceutical company focused on developing innovative therapeutics that address unmet medical needs in neurology, oncology, ophthalmology, and inflammation. Founded in 2015 and headquartered in Redwood City, California, with research facilities in Baltimore, Maryland, the company specializes in hydroxyl dendrimer therapeutics. These products are designed to selectively target and treat diseases by engaging actively endocytosing cells such as reactive microglia and macrophages, which play a critical role in chronic inflammation and disease progression. By utilizing this precision targeting approach, Ashvattha Therapeutics aims to minimize off-target toxicity, systemic side effects, and immunogenicity often associated with conventional treatments, thereby enhancing treatment efficacy and patient outcomes. The company has a robust pipeline containing nine therapeutics across its areas of focus.
Diligent Robotics
Series A in 2020
Diligent Robotics Inc. is a company that specializes in the development and manufacturing of hospital service robots. Founded in 2017 and headquartered in Austin, Texas, the company has created Moxi, a robotic assistant designed to support clinical and nursing staff with logistical tasks in hospital settings. Moxi is equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities, allowing it to collaborate effectively with human teams. By automating routine logistical duties, Moxi enables healthcare providers to focus more on direct patient care, thereby enhancing patient satisfaction, service quality, and safety in healthcare environments. The company also develops artificial intelligence-based software suites that allow its robots to adapt to and thrive in dynamic, semi-structured environments.
Mammoth Biosciences
Series B in 2020
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, founded in 2017 by CRISPR pioneer Jennifer Doudna and other key innovators. The company specializes in developing advanced CRISPR technologies, including its proprietary DETECTR platform, which enables the rapid detection of specific nucleic acids associated with various diseases. This platform facilitates diagnostic applications such as cancer screening, bacterial infections, and viral infections, allowing for real-time and simultaneous testing of multiple conditions. In addition to diagnostics, Mammoth Biosciences works on genome editing solutions for therapeutic purposes, targeting areas such as immuno-oncology, autoimmune diseases, and liver disorders. The company aims to democratize disease detection and enhance life science research through innovative, affordable, and efficient tools, while also leveraging its exclusive licensing of various Cas proteins for improved diagnostics and therapeutic applications.
Einride AB, established in 2016, specializes in sustainable freight transportation. Headquartered in Stockholm, Sweden, with additional offices in Gothenburg and Palo Alto, the company manufactures electric trucks, known as Einride Pods, for road freight. These vehicles are designed for autonomous operation, reducing emissions and enhancing safety. Einride also offers digital platforms for clients to plan, order, and track shipments, providing real-time data and insights. Notably, Einride became the first company to operate an autonomous, electric freight vehicle on a public road in 2019.
Evrnu is a textile innovations company that specializes in producing engineered fibers from discarded clothing. By employing advanced regenerative fiber technologies, the company transforms textile waste into high-quality fiber sources. Its process involves breaking down cotton garment waste to the molecular level and reconstructing it into new, useful products. Evrnu's offerings include regenerative cellulosic and polyester fibers, as well as recoverable stretch materials, which provide significant environmental benefits. Through these innovations, Evrnu aims to create a circular ecosystem in the textile industry, promoting sustainability and reducing waste.
Node
Venture Round in 2019
Node, recently acquired by SugarCRM, fuels Sugar's time-aware CX platform to help businesses by automatically forecasting expected outcomes and highlighting previously unforeseen challenges and opportunities. Extending Sugar’s time-aware CX platform, Node’s AI technology adds the most coveted element of time—the future. The combined solution offers wide-ranging capabilities for sales, marketing, and service teams. Node enables users of business applications to see into the future. Powered by Artificial Intuition™ technology, Node is the first turnkey AI-as-a-service platform focused on powering predictable business outcomes, which enterprises can use to quickly and seamlessly build advanced AI into both customer-facing and internal applications without investing years and millions of dollars on risky AI experiments. Applications powered by Node can deliver predictions that enable users to make smarter connections and decisions about how to engage with customers, employees, investors, and partners. Node was founded by Google's youngest employee, Falon Fatemi, and it's renowned technology team includes the Godfather of Search, Louis Monier who created Alta Vista, and Michael Radovancevich former CTO of Taleo and OpenX. Node is backed by Mark Cuban, NEA, Avalon Ventures, and JetBlue Technology Ventures.
BioEclipse Therapeutics
Series A in 2019
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Francisco, California, focused on developing innovative immune-oncology therapeutics for cancer treatment. The company specializes in a proprietary approach that combines activated immune cells with an adapted oncolytic virus, which selectively targets and destroys malignant cells. This method enhances the immune system's ability to recognize and attack tumors, leading to curative treatments across a wide range of tumor types. BioEclipse aims to improve clinical outcomes and the quality of life for cancer patients, striving to advance the field of oncology toward making cancer a curable disease. Established in 2006 and previously known as ConcentRx Inc., the company rebranded in 2017 to reflect its commitment to pioneering immune therapies without requiring the reengineering of patients' own cells.
Bitwise Industries
Series A in 2019
Bitwise Industries Inc. is a technology ecosystem company based in Fresno, California, focused on enhancing the local technology landscape. Established in 2013, the company operates Geekwise Academy, which provides accelerated coding education aimed at individuals of all ages, particularly from marginalized backgrounds. In addition to educational services, Bitwise Industries runs a custom software development firm, Shift3 Technologies, that connects experienced developers with entry-level programmers to create software solutions. The company also fosters community and collaboration by developing tech venues and co-working spaces that serve as hubs for technologists and technology companies. Through these initiatives, Bitwise Industries aims to empower individuals with vital tech skills and create pathways to meaningful careers in the technology sector.
One Concern
Series B in 2019
One Concern, Inc. is a climate resilience technology company that develops an artificial intelligence-based platform to assist governments and organizations in preparing for and responding to natural disasters. Founded in 2015 and headquartered in Menlo Park, California, with an additional office in Tokyo, Japan, One Concern utilizes machine learning, hazard modeling, and predictive analytics to create post-disaster damage maps and provide daily situational reports. Its flagship tool, Seismic Concern, focuses on earthquake preparedness and response, while the platform also addresses various disasters like hurricanes, floods, and wildfires, as well as chronic stresses such as poverty and climate change. By delivering capabilities throughout the lifecycle of disaster preparedness, mitigation, response, and recovery, One Concern aims to make disasters less devastating and enhance overall community resilience. Recognized as a 2019 Technology Pioneer, the company is part of the World Economic Forum’s Global Innovators community.
Markable Creators
Series A in 2019
Markable Creators is a pioneering company that specializes in transforming visual content into shoppable experiences through its advanced image recognition technology. The platform leverages computer vision and deep learning to identify fashion items in videos and images, allowing viewers to seamlessly shop for products they see in various digital media. With a focus on social commerce, Markable Creators connects users to a diverse range of e-commerce platforms, offering access to millions of products that are continuously updated to ensure availability. The company has established partnerships with major social content platforms in Asia, enhancing its reach and impact in the market. By bridging the gap between social media content and online shopping, Markable Creators is at the forefront of a significant shift in how consumers discover and purchase fashion items.
Ketos, Inc., operating as Ketos7 Inc., specializes in providing innovative hardware and software analytics solutions for water management. Founded in 2015 and based in Milpitas, California, the company offers a vertically integrated water intelligence platform that includes industrial-grade hardware, an IoT communication framework, and a comprehensive software platform. Ketos focuses on real-time monitoring and analysis of water systems, enabling clients to measure and manage key water quality parameters such as pH, dissolved solids, hardness, turbidity, and salinity. Its technology is designed for a variety of applications, including agricultural, industrial, and municipal settings, and aims to enhance water efficiency and quality. By leveraging automated reporting and predictive analytics, Ketos provides actionable insights that help organizations address critical water management challenges effectively.
Mammoth Biosciences
Series A in 2018
Mammoth Biosciences, Inc. is a biotechnology company based in South San Francisco, California, founded in 2017 by CRISPR pioneer Jennifer Doudna and other key innovators. The company specializes in developing advanced CRISPR technologies, including its proprietary DETECTR platform, which enables the rapid detection of specific nucleic acids associated with various diseases. This platform facilitates diagnostic applications such as cancer screening, bacterial infections, and viral infections, allowing for real-time and simultaneous testing of multiple conditions. In addition to diagnostics, Mammoth Biosciences works on genome editing solutions for therapeutic purposes, targeting areas such as immuno-oncology, autoimmune diseases, and liver disorders. The company aims to democratize disease detection and enhance life science research through innovative, affordable, and efficient tools, while also leveraging its exclusive licensing of various Cas proteins for improved diagnostics and therapeutic applications.
Aclima Inc. is a climate-tech company that specializes in designing and deploying large-scale environmental sensor networks. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Portland, Oregon, and New York City, Aclima focuses on measuring and analyzing air pollution and greenhouse gases with exceptional detail and precision. Its advanced measurement and analysis platforms generate real-time streaming data, which is processed and translated into actionable insights for governments, businesses, and communities through its professional analytics software, Aclima Pro. By providing block-by-block resolution and source-level insights, Aclima aims to catalyze significant climate action that protects public health, reduces emissions, and ensures clean air for all.
Shine is a developer of a self-care communication application designed to make well-being accessible. Their application is a messaging bot that gives out life advice and positive reinforcements including actionable tips based on confidence, daily happiness, mental health, productivity, and self-care audio challenges to grow on the go through sms texts on a daily basis, enabling people with anxiety and depression to get career and life advice to take proper care of themselves.
BioEclipse Therapeutics
Seed Round in 2018
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Francisco, California, focused on developing innovative immune-oncology therapeutics for cancer treatment. The company specializes in a proprietary approach that combines activated immune cells with an adapted oncolytic virus, which selectively targets and destroys malignant cells. This method enhances the immune system's ability to recognize and attack tumors, leading to curative treatments across a wide range of tumor types. BioEclipse aims to improve clinical outcomes and the quality of life for cancer patients, striving to advance the field of oncology toward making cancer a curable disease. Established in 2006 and previously known as ConcentRx Inc., the company rebranded in 2017 to reflect its commitment to pioneering immune therapies without requiring the reengineering of patients' own cells.
Vyv, formerly known as Vital Vio, Inc., is a company based in Troy, New York, that specializes in the design, engineering, and manufacturing of advanced antimicrobial lighting systems branded as VioSafe. Founded in 2012, Vyv offers a range of products, including under cabinet lights, T8 replacement bulbs, and various LED luminaires, all engineered to continuously combat germs and infectious pathogens. These innovative lighting solutions are utilized in diverse commercial settings such as hospitals, laboratories, food storage facilities, and educational institutions, aiming to enhance infection control and promote public health. Vyv's technology leverages visible light to disrupt the cell membranes of harmful microorganisms, effectively reducing their presence in environments where hygiene is critical. The company's clientele includes prominent institutions like Duke University and UCLA Health, underscoring its commitment to providing safe and effective lighting solutions across various sectors.
Vow To Be Chic
Venture Round in 2017
Vow To Be Chic is an online platform specializing in the rental of designer bridesmaid dresses and Little White Dresses, providing an accessible solution for the bridesmaid experience. By offering services such as at-home try-on, shipping, dry cleaning, and insurance, the company alleviates the financial burden typically associated with being a bridesmaid, which averages around $1,700 when considering dress purchases and related expenses. This service also addresses the logistical challenges of coordinating dress selection and fittings for bridesmaids located across the country. Vow To Be Chic aims to enhance convenience and affordability in the wedding planning process, allowing bridesmaids to wear stylish dresses without the pressure of significant costs or time commitments.
ThinkCERCA
Series B in 2017
ThinkCERCA is an educational technology company that offers a personalized literacy platform aimed at enhancing students' reading, writing, and critical thinking skills through argumentative writing. The platform enables educators to design, share, deliver, and assess lessons while tracking real-time progress in reading and writing. It fosters collaborative discussions and debates in classrooms, allowing students to engage with various subjects through the process of argumentation. With a presence in all 50 states and 130 countries, ThinkCERCA has partnered with notable education leaders and has received recognition for its innovative approach, including being a finalist for the SIAA CODiE Awards and being featured by The Atlantic and EdSurge. The company has also been acknowledged by Common Sense’s Graphite as one of the best tools in educational technology.
Tinkergarten
Series A in 2017
Tinkergarten, Inc. is a company that specializes in outdoor play-based learning classes for children aged 18 months to 8 years. Founded in 2014 and headquartered in Northampton, Massachusetts, Tinkergarten focuses on providing authentic early childhood education through engaging activities. The company connects families with local leaders who facilitate these activity-based classes, fostering skill development in a natural environment. By offering a network of community leaders, Tinkergarten enhances the learning experience, allowing children to grow in confidence and capability while enjoying the benefits of outdoor play.
Markable Creators
Venture Round in 2017
Markable Creators is a pioneering company that specializes in transforming visual content into shoppable experiences through its advanced image recognition technology. The platform leverages computer vision and deep learning to identify fashion items in videos and images, allowing viewers to seamlessly shop for products they see in various digital media. With a focus on social commerce, Markable Creators connects users to a diverse range of e-commerce platforms, offering access to millions of products that are continuously updated to ensure availability. The company has established partnerships with major social content platforms in Asia, enhancing its reach and impact in the market. By bridging the gap between social media content and online shopping, Markable Creators is at the forefront of a significant shift in how consumers discover and purchase fashion items.
Cordex Systems
Series A in 2017
Cordex Systems designs and manufactures a cardiovascular diagnostic device. Its product includes the Cordex EnDys System is a diagnostic tool that provides both early detection and ongoing monitoring of cardiovascular disease by measuring endothelial dysfunction.
EpiBone
Convertible Note in 2016
EpiBone, Inc. is a biotechnology company based in Brooklyn, New York, that specializes in developing advanced bone and cartilage reconstruction solutions. Founded in 2013, EpiBone leverages innovative techniques involving patient-specific bone scans and the use of the patient's own stem cells to create autologous-like bone grafts. These grafts are cultivated in custom bioreactors, promoting efficient bone formation and regeneration. EpiBone's lead product, an anatomically precise living 3D bone graft, successfully completed its Phase I/IIa clinical trial in August 2023, while the company is also developing a cartilage repair portfolio that includes an allogeneic osteochondral plug and an injectable cartilage filler. This pioneering work positions EpiBone at the forefront of regenerative medicine, aiming to transform orthopedic repair and improve patient outcomes through a streamlined surgical approach and reduced recovery times.
Tinkergarten
Seed Round in 2016
Tinkergarten, Inc. is a company that specializes in outdoor play-based learning classes for children aged 18 months to 8 years. Founded in 2014 and headquartered in Northampton, Massachusetts, Tinkergarten focuses on providing authentic early childhood education through engaging activities. The company connects families with local leaders who facilitate these activity-based classes, fostering skill development in a natural environment. By offering a network of community leaders, Tinkergarten enhances the learning experience, allowing children to grow in confidence and capability while enjoying the benefits of outdoor play.
Talent Sonar
Series A in 2016
Talent Sonar, following its merger with TalVista, focuses on assisting companies in managing unconscious bias to enhance diversity hiring practices. Through services such as redacted resume review, job description optimization, and structured interviews, Talent Sonar aims to help organizations create more inclusive and equitable recruitment processes. By leveraging technology and data-driven approaches, Talent Sonar aims to support companies in building diverse and talented teams.
Trustify
Seed Round in 2015
Trustify, Inc. operates an on-demand technology platform that connects clients with licensed private investigators across the United States. Established in 2015 and headquartered in Arlington, Virginia, the company provides a range of services, including real-time observation, digital monitoring, background checks, and social media analysis. Trustify facilitates various investigative needs, such as locating witnesses, serving legal papers, asset recovery, and evidence collection for law enforcement. Additionally, it offers specialized support for insurance-related investigations, covering areas like workers' compensation, scene investigations, and liability assessments. By leveraging its network of professionals, Trustify aims to make truth, trust, and safety accessible to a broader audience.